SAM #75F40126Q134903

FDA Procurement of Primary Human Trophoblast Cells for Toxicology Research

The U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), Division of Biochemical Toxicology (DBT) is seeking to procure specialized biological materials for research: - Government Buyer: - U.S. Food and Drug Administration (FDA) - National Center for Toxicological Research (NCTR) - Division of Biochemical Toxicology (DBT) - Products/Services Requested: - 20 vials of Primary Human Trophoblast Cells - Each vial must contain at least one million viable cells - Cells must have >80% post-thaw viability - Cells sourced from individual female donors - Cells must form confluent monolayers with cobblestone morphology, distinct nuclei, and tight junctions for at least three days - Cells must be characterized to confirm trophoblast-specific features - Donor demographic information and cause of death (if available) must be provided - Compatible thawing, plating, and maintenance media must be offered - Unique/Notable Requirements: - Cells must be plateable and cryopreserved - Strict viability and morphological criteria - Detailed donor information required - Delivery must avoid federal holidays and closures - Firm-fixed-price contract; no advance payments - OEMs/Vendors: - No specific OEMs or vendors are named; opportunity is open to qualified suppliers of primary human trophoblast cells

Description

See Attached Combined Synopsis/Solicitation 75F40126Q134903

View original listing